Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 69,579
Sort by:

Barth Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Barth Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Barth Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 36 pages

Bcr-Abl Tyrosine Kinase (EC 2.7.10.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Bcr-Abl Tyrosine Kinase (EC 2.7.10.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Bcr-Abl Tyrosine Kinase (EC 2.7.10.2) Drugs in Deve...

May 2022 61 pages

Benign Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Benign Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Benign Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 81 pages

Beta 1 Adrenergic Receptor (Beta 1 Adrenoreceptor or ADRB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Beta 1 Adrenergic Receptor (Beta 1 Adrenoreceptor or ADRB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Beta 1 Adrenergic Receptor (B...

May 2022 70 pages

Beta 2 Adrenergic Receptor (Beta 2 Adrenoreceptor or ADRB2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Beta 2 Adrenergic Receptor (Beta 2 Adrenoreceptor or ADRB2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Beta 2 Adrenergic Receptor (B...

May 2022 97 pages

Beta 3 Adrenergic Receptor (Beta 3 Adrenoreceptor or ADRB3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Beta 3 Adrenergic Receptor (Beta 3 Adrenoreceptor or ADRB3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Beta 3 Adrenergic Receptor (B...

May 2022 41 pages

Beta Adrenergic Receptor (ADRB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Beta Adrenergic Receptor (ADRB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Beta Adrenergic Receptor (ADRB) Drugs in Development by T...

May 2022 131 pages

Beta Galactosidase (Acid Beta Galactosidase or Lactase or Elastin Receptor 1 or GLB1 or EC 3.2.1.23) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Beta Galactosidase (Acid Beta Galactosidase or Lactase or Elastin Receptor 1 or GLB1 or EC 3.2.1.23) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Play...

May 2022 41 pages

Beta Glucuronidase (Beta G1 or Beta D Glucuronidase or GUSB or EC 3.2.1.31) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Beta Glucuronidase (Beta G1 or Beta D Glucuronidase or GUSB or EC 3.2.1.31) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Beta Glucuron...

May 2022 36 pages

Beta Tubulin (TUBB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Beta Tubulin (TUBB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Beta Tubulin (TUBB) Drugs in Development by Therapy Areas and Indicat...

May 2022 38 pages

Biliary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Biliary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Biliary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 52 pages

Bipolar Disorder (Manic Depression) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Bipolar Disorder (Manic Depression) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bipolar Disorder (Manic Depression) Drugs in Development by Stages, Target,...

May 2022 75 pages

Bleeding And Clotting Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Bleeding And Clotting Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bleeding And Clotting Disorders Drugs in Development by Stages, Target, MoA, RoA...

May 2022 266 pages

Blepharospasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Blepharospasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Blepharospasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 36 pages

Blood Coagulation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Blood Coagulation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Blood Coagulation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 45 pages

Bone Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Bone Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bone Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 263 pages

Bone Fracture Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Bone Fracture Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bone Fracture Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 61 pages

Bone Regeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Bone Regeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bone Regeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 43 pages

Bone Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Bone Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bone Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 236 pages

Born Small For Gestational Age (SGA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Born Small For Gestational Age (SGA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Born Small For Gestational Age (SGA) Drugs in Development by Stages, Target...

May 2022 35 pages

Brachyury Protein (Protein T or T) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Brachyury Protein (Protein T or T) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Brachyury Protein (Protein T or T) Drugs in Developmen...

May 2022 36 pages

Brain Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Brain Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Brain Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 161 pages

Brain Derived Neurotrophic Factor (Abrineurin or BDNF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Brain Derived Neurotrophic Factor (Abrineurin or BDNF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Brain Derived Neurotrophic Factor...

May 2022 43 pages

Brain (Head) Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Brain (Head) Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Brain (Head) Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 35 pages

Brain Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Brain Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Brain Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 50 pages

Brain Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Brain Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Brain Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 119 pages

Bronchiolitis Obliterans Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Bronchiolitis Obliterans Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bronchiolitis Obliterans Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 39 pages

Burkholderia Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Burkholderia Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Burkholderia Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 45 pages

Burkitt Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Burkitt Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Burkitt Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 94 pages

C-C Chemokine Receptor Type 2 (Monocyte Chemoattractant Protein 1 Receptor or CD192 or CCR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

C-C Chemokine Receptor Type 2 (Monocyte Chemoattractant Protein 1 Receptor or CD192 or CCR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMM...

May 2022 40 pages

C-C Chemokine Receptor Type 9 (G Protein Coupled Receptor 28 or GPR 9-6 or CDw199 or CCR9) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

C-C Chemokine Receptor Type 9 (G Protein Coupled Receptor 28 or GPR 9-6 or CDw199 or CCR9) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMAR...

May 2022 35 pages

Cachexia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Cachexia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cachexia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an ov...

May 2022 51 pages

Calcineurin (Protein Serine-Threonine Phosphatase 3 or Protein Phosphatase 3 or EC 3.1.3.16) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Calcineurin (Protein Serine-Threonine Phosphatase 3 or Protein Phosphatase 3 or EC 3.1.3.16) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMM...

May 2022 75 pages

Calcium Activated Neutral Protease (Calpain or CANP or CAPN or EC 3.4.22.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Calcium Activated Neutral Protease (Calpain or CANP or CAPN or EC 3.4.22.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Calcium Activa...

May 2022 52 pages

Calcium Activated Potassium Channel Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Calcium Activated Potassium Channel Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Calcium Activated Potassium Channel Drugs in Developm...

May 2022 51 pages

Calcium-Calmodulin Dependent Protein Kinase Type II (CAMK2 or EC 2.7.11.17) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Calcium-Calmodulin Dependent Protein Kinase Type II (CAMK2 or EC 2.7.11.17) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Calcium/Calmo...

May 2022 39 pages

Calcium Release Activated Calcium Channel Protein 1 (Protein Orai 1 or Transmembrane Protein 142A or ORAI1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Calcium Release Activated Calcium Channel Protein 1 (Protein Orai 1 or Transmembrane Protein 142A or ORAI1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and K...

May 2022 41 pages

Calcium Sensing Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Calcium Sensing Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Calcium Sensing Receptor Drugs in Development by Therapy Areas a...

May 2022 40 pages

Calreticulin (Calregulin or Endoplasmic Reticulum Resident Protein 60 or CRP55 or HACBP or grp60 or CALR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Calreticulin (Calregulin or Endoplasmic Reticulum Resident Protein 60 or CRP55 or HACBP or grp60 or CALR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 39 pages

cAMP Specific 3,5 Cyclic Phosphodiesterase 4B (DPDE4 or PDE32 or PDE4B or EC 3.1.4.53) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

cAMP Specific 3,5 Cyclic Phosphodiesterase 4B (DPDE4 or PDE32 or PDE4B or EC 3.1.4.53) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY cA...

May 2022 36 pages

Cancer-Testis Antigen 1 (Autoimmunogenic Cancer-Testis Antigen NY ESO 1 or Cancer-Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Cancer-Testis Antigen 1 (Autoimmunogenic Cancer-Testis Antigen NY ESO 1 or Cancer-Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) Drugs in Development by Therapy Areas and Indicat...

May 2022 48 pages

Cannabinoid Receptor 1 (CB1 or CANN6 or CNR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Cannabinoid Receptor 1 (CB1 or CANN6 or CNR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Cannabinoid Receptor 1 (CB1 or CANN6 or CNR...

May 2022 298 pages

Cannabinoid Receptor 2 (CB2 or CX5 or CNR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Cannabinoid Receptor 2 (CB2 or CX5 or CNR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Cannabinoid Receptor 2 (CB2 or CX5 or CNR2) D...

May 2022 292 pages

Carbonic Anhydrase 9 (Carbonate Dehydratase IX or pMW1 or Membrane Antigen MN or P54-58N or Renal Cell Carcinoma Associated Antigen G250 or CA9 or EC 4.2.1.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Carbonic Anhydrase 9 (Carbonate Dehydratase IX or pMW1 or Membrane Antigen MN or P54-58N or Renal Cell Carcinoma Associated Antigen G250 or CA9 or EC 4.2.1.1) Drugs in Development by Therapy Areas and...

May 2022 40 pages

Carbonic Anhydrase (Carbonate Dehydratase or Carbonic Acid Anhydrase or Carboxyanhydrase or CA or EC 4.2.1.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Carbonic Anhydrase (Carbonate Dehydratase or Carbonic Acid Anhydrase or Carboxyanhydrase or CA or EC 4.2.1.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and...

May 2022 54 pages

Carcinoembryonic Antigen (CEA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Carcinoembryonic Antigen (CEA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Carcinoembryonic Antigen (CEA) Drugs in Development by The...

May 2022 51 pages

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) Drugs in Development by Therapy Areas and Indications, Stages, M...

May 2022 38 pages

Carcinoid Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Carcinoid Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Carcinoid Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 40 pages

Carcinomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Carcinomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Carcinomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides a...

May 2022 266 pages

Cardiometabolic Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Cardiometabolic Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cardiometabolic Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 47 pages

Filters

Search

Categories

836
28
208
156
143
133
127
93
65,439
803
718
772
123

Publishers

179
1
239
158
389
103
444
148
425
3
202
3
6
1,620
487
76
123
208
111
25
212
1,049
378
23
40
68
472
277
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
1,790
60
1,696
8
8,921
2,212
4,495
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
323
8
3
18
58
901
6
89
12
24
15
1,285
227
128
386
3
74
10
119
228
46
474
26
133
4

Regions

92
58
45
43
41
35
31
30
30
29
28
28
28
26
16
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
790
495
2
2
2
117
194
102
53
23
704
26
136
526
174
623
64,568

Price

Date

Pages

Offers

1
280
1
1